PPA
CLSD

Parametric Portfolio Associates’s Clearside Biomedical CLSD Stock Holding History

Parametric Portfolio Associates’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-713
Closed -$11K – 3933
2018
Q4 		$11K Buy
+713
New +$33.5K ﹤0.01% 3894
2018
Q2 		– Sell
-4,509
Closed -$726K – 3889
2018
Q1 		$726K Buy
+4,509
New +$549K ﹤0.01% 3172
2017
Q3 		– Sell
-895
Closed -$122K – 4029
2017
Q2 		$122K Buy
+895
New +$107K ﹤0.01% 3907

Other funds holding CLSD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Parametric Portfolio Associates's CLSD Position: Q1 2019 in Review

Parametric Portfolio Associates sold out of Clearside Biomedical (CLSD) in Q1 2019, closing a stake of 713 shares — an estimated $11K sold.

Parametric Portfolio Associates first reported a position in CLSD in Q2 2017 and held it in 3 quarters. The position peaked at $726K in Q1 2018. 57 funds tracked by Wall St. Rank hold CLSD as of Q1 2019.

  • Parametric Portfolio Associates reported no remaining Clearside Biomedical position as of Q1 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 713 Clearside Biomedical shares in Q1 2019, an estimated $11K.
  • Parametric Portfolio Associates first reported a position in Clearside Biomedical in Q2 2017 and held it in 3 quarters.
  • Parametric Portfolio Associates's Clearside Biomedical position peaked at $726K in Q1 2018.
  • 57 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2019.

Based on Parametric Portfolio Associates's 13F filing for Q1 2019, filed 9 May 2019.